New NICE Guidelines – identification and management of adrenal insufficiency
The publication of new NICE (National Institute for Health and Care Excellence) guidelines – “Adrenal insufficiency: identification and management” marks a significant advancement in the management and treatment of primary, secondary and tertiary adrenal insufficiency.
These guidelines provide updated, evidence-based recommendations designed to improve diagnosis, treatment, and long-term care for individuals with adrenal insufficiency.
By setting clear standards, the new guidelines aim to enhance patient outcomes, ensure timely interventions, and reduce assoicated risks – including that of adrenal crisis.
Read the guidelines on the NICE website here.
Recent Blog Posts
New report highlights access gap for innovative medicines
The CAH Support Group recently provided input into a new Medicines Australia report about access to innovative medicines in Australia. The report, now published, warns that Australian patients are missing access to some innovative medicines available in comparable...
Help Shape New UK Sick Day Guidance for Young People with Adrenal Insufficiency
Young people with adrenal insufficiency (including CAH and Addison's disease) and parents/carers are being invited to help shape new UK-wide resources on sick day rules and emergency management. The project is being led by Edge Hill University in partnership with the...
Article: Adult Quality of Life with CAH
A new study published in Endocrine Connections explores the lived experiences of adults with congenital adrenal hyperplasia (CAH) and the wide-ranging impact the condition can have on quality of life. Through in-depth interviews with adults living with CAH as well as...